by GlobeNewsWire | Jun 20, 2016 | Globe Newswire
PLYMOUTH MEETING, Pa. and SEOUL, South Korea, June 20, 2016 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and GeneOne Life Science, Inc. (KSE:011000) today announced that they have received approval to initiate a phase I human trial to evaluate...
by GlobeNewsWire | May 17, 2016 | Globe Newswire
Dover,DE, May 17, 2016 (GLOBE NEWSWIRE) — Molecular Diagnostics Market size, is poised to hit USD 10.03 billion by 2023; as per the latest research report by Global Market Insights, Inc. Strong and consistent regulatory support, encouraging R&D spending,...
by GlobeNewsWire | May 9, 2016 | Globe Newswire
PLYMOUTH MEETING, Pa., May 09, 2016 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today reported financial results for the quarter ended March 31, 2016. Total revenue was $8.1 million for the three months ended March 31, 2016, compared to $5.2...
by GlobeNewsWire | Apr 25, 2016 | Globe Newswire
Deerfield Beach, FL, April 25, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Vaccine Market by Technology (Inactivated, Subunit, Conjugate, Live Attenuated, Toxoid, and Dendritic Cell Synthetic), Type (Therapeutic, Preventive),...
by GlobeNewsWire | Apr 25, 2016 | Globe Newswire
AMES, Iowa, April 25, 2016 (GLOBE NEWSWIRE) — NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel immuno-oncology and infectious disease product candidates, announced today...